PDGFR (PDGFRa or PDGFRb)‐specific deletion in CD34+ cells in vivo revealed that CD34+ cells give rise to Periostin+ myofibroblasts through PDGFRb and not PDGFRa, whereas both receptors are required for CD34+ cell proliferation in AAA. Here, CD34 is linked to triple-A syndrome.